Ahead of the Borealis Psychedelic Science Summit in Stockholm (September 26–27), we invite you to join an engaging webinar exploring psychedelics in the treatment of anxiety disorders.
Research into psychedelic-assisted therapy for anxiety is rapidly expanding, and clinical psychologist Jason Luoma is at the forefront with his pioneering trial of MDMA-assisted therapy for Social Anxiety Disorder. In conversation with psychologist Filip Bromberg, Jason will discuss how psychedelic treatments can extend beyond MDMA, explore the role of Acceptance and Commitment Therapy (ACT) in addressing anxiety and avoidance, and examine the opportunities and challenges these innovative approaches bring to mental health treatment.
- Time & Date: September 16th, 19.00 CEST
- The webinar is free, but registration is required! Register here:
https://us06web.zoom.us/webinar/register/WN_XK7sJo8WTIK_mm5pXaK7nw
Deepen Your Experience
Jason Luoma will also lead a full-day, in-person workshop in Stockholm on September 25, providing clinicians an in-depth exploration of how ACT principles enhance psychedelic therapy, from preparation through integration.
More about the workshop →
https://borealissummit.com/enhancing-psychedelic-assisted-therapy-with-acceptance-and-commitment-therapy
About Jason Luoma
Dr. Jason Luoma is a clinical psychologist, researcher, and internationally recognized expert in Acceptance and Commitment Therapy (ACT). As co-founder of Portland Psychotherapy Clinic, Research & Training Center, he integrates scientific rigor with compassionate practice. He has led groundbreaking research into MDMA-assisted therapy and will speak at the upcoming Borealis Psychedelic Science Summit.
This webinar is hosted by the Borealis Psychedelic Science Summit in collaboration with the Swedish psychedelic education company Lavin.
Learn more at:
https://borealissummit.com
https://www.lavin.education
You may also like the following events from Lavin:
Also check out other
Workshops in wackersdorf,
Virtual events in wackersdorf.
